Teesson Maree, Whiteford Harvey, Bower Marlee, Smout Scarlett, Burgess Philip, Harris Meredith G, Pirkis Jane, Diminic Sandra, Baillie Andrew, Slade Tim, Chapman Cath
The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, NSW, Australia.
The University of Queensland, Brisbane, QLD, Australia.
Aust N Z J Psychiatry. 2025 Jun;59(6):485-492. doi: 10.1177/00048674241292961. Epub 2024 Nov 7.
The objective of this paper is to summarise the policy implications of key findings from the 2020-22 Australian National Study of Mental Health and Wellbeing (NSMHWB). We provide an analysis of policy implications of four papers in this issue of the journal from the 2020-22 NSMHWB ( = 15,893) and the 2007 NSMHWB ( = 8841). The 2020-2022 NSMHWB reported a lifetime prevalence rate of common mental disorders of 40.2% (95% confidence interval [CI] = 39.2-41.3) and 12-month prevalence rate of 20.2% (95% CI 19.5-21.0). Overall, adult Australians were significantly more likely to experience a 12-month mental disorder in 2020-22 compared with 2007, with the change most striking in among those aged 16-24 years (odds ratio [OR] 1.2, 95% CI 1.1-1.3). Individuals aged 16-24 years in 2020-22 were significantly more likely to experience a 12-month anxiety disorder (OR 2.9, 95% CI = 2.3-3.7, depressive disorder (OR 2.8 95% CI = 2.1-3.9) or comorbidity (relative risk [RR] = 1.4, 95% CI = 1.2-1.7) compared with those aged 16-24 years in 2007. In 2020-22, the proportion of Australians who had experienced suicidal ideation, suicide plans and suicide attempts in the past 12 months was 3.3%, 1.1% and 0.3%. Under half (46.5% 95% CI 44.1-48.8) of adults with a 12-month mental disorder sought treatment. Mental disorders remain an endemic feature of Australia's overall health landscape and appear to be increasing, especially in younger cohorts. While service use rates have improved over time, there is still some way to go. Epidemiological surveys such as the 2020-22 NSMHWB are important for understanding changing prevalence and the population not accessing services. Innovative prevention and treatment strategies will be needed to address the increasing rates of disorders in younger Australian adults. Equally innovative and bold policy responses will be essential.
本文的目的是总结2020 - 2022年澳大利亚全国心理健康与幸福状况研究(NSMHWB)主要研究结果的政策含义。我们对本期杂志中来自2020 - 2022年NSMHWB(n = 15,893)和2007年NSMHWB(n = 8841)的四篇论文的政策含义进行了分析。2020 - 2022年NSMHWB报告常见精神障碍的终生患病率为40.2%(95%置信区间[CI]=39.2 - 41.3),12个月患病率为20.2%(95% CI 19.5 - 21.0)。总体而言,与2007年相比,2020 - 2022年澳大利亚成年人在过去12个月内患精神障碍的可能性显著增加,这一变化在16 - 24岁人群中最为明显(优势比[OR] 1.2,95% CI 1.1 - 1.3)。与2007年16 - 24岁的人群相比,2020 - 2022年16 - 24岁的人群在过去12个月内患焦虑症(OR 2.9,95% CI = 2.3 - 3.7)、抑郁症(OR 2.8,95% CI = 2.1 - 3.9)或共病(相对风险[RR]=1.4,95% CI = 1.2 - 1.7)的可能性显著更高。在2020 - 2022年,过去12个月内有自杀意念、自杀计划和自杀未遂经历的澳大利亚人的比例分别为3.3%、1.1%和0.3%。患有12个月精神障碍的成年人中,不到一半(46.5%,95% CI 44.1 - 48.8)寻求过治疗。精神障碍仍然是澳大利亚整体健康状况的一个普遍特征,而且似乎在增加,尤其是在年轻人群体中。虽然随着时间推移服务使用率有所提高,但仍有很长的路要走。像2020 - 2022年NSMHWB这样的流行病学调查对于了解患病率的变化以及未获得服务的人群很重要。需要创新的预防和治疗策略来应对澳大利亚年轻成年人中精神障碍发病率不断上升的问题。同样,创新且大胆的政策回应也至关重要。